Get the Stockscreener App
79.97
0.59%
0.47
Pre-market:
79.73
-0.24
-0.30%
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $79.97, with a volume of 999.50K.
It is up +0.59% in the last 24 hours and up +6.03% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$79.50
Open:
$79.67
24h Volume:
999.50K
Relative Volume:
0.49
Market Cap:
$39.28B
Revenue:
$10.19B
Net Income/Loss:
$1.05B
P/E Ratio:
38.00
EPS:
2.1044
Net Cash Flow:
$1.38B
1W Performance:
+1.48%
1M Performance:
+6.03%
6M Performance:
-5.66%
1Y Performance:
-5.00%
1-Day Range:
$79.43
$80.25
1-Week Range:
$78.28
$80.28
52-Week Range:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
79.97 | 39.05B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
572.47 | 199.19B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.59 | 55.57B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
244.94 | 35.40B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
41.65 | 31.09B | 0 | 0 | 0 | 0.00 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon - marketscreener.com
Broadwood Partners denounces STAAR Surgical's delay of shareholder vote on Alcon deal - marketscreener.com
Is Alcon Inc. stock a safe haven assetJuly 2025 Movers & Technical Buy Zone Confirmations - ulpravda.ru
Can Alcon Inc. stock deliver consistent earnings growth2025 Major Catalysts & Verified Momentum Watchlists - ulpravda.ru
Is Alcon Inc. stock a buy on dipsJuly 2025 Final Week & Growth Focused Stock Pick Reports - ulpravda.ru
Why analysts remain bullish on Alcon Inc. stock2025 Big Picture & Capital Protection Trade Alerts - ulpravda.ru
Published on: 2025-12-20 10:10:42 - ulpravda.ru
Why Alcon Inc. stock could rally in 2025CPI Data & AI Powered Market Trend Analysis - ulpravda.ru
Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for - Investing.com UK
Alcon (ALC) Faces Opposition in STAAR Surgical Acquisition - GuruFocus
Will Alcon Inc. (2U3) stock see valuation expansionBull Run & Weekly Return Optimization Plans - ulpravda.ru
STAAR Surgical (STAA) Rises Amid Adjourned Shareholder Vote on A - GuruFocus
Big STAAR shareholder fights yet another delay on sale to Alcon - Stock Titan
Alcon (ALC) Postpones Special Meeting to January 2026 - GuruFocus
Alcon Exercises Right to Require STAAR Surgical to Delay Stockholder Meeting - marketscreener.com
Alcon Exercises Right To Require STAAR Surgical To Adjourn Its Special Meeting Of Stockholders - TradingView — Track All Markets
Eye implant maker delays shareholder vote on merger with Alcon - Stock Titan
Alcon exercises right to require Staar Surgical to adjourn its special meeting of stockholders, now will be held January 6 - marketscreener.com
Can Alcon Inc. Ordinary Shares stock surprise with quarterly resultsEarnings Risk Report & Long-Term Safe Investment Plans - DonanımHaber
What Wall Street predicts for Alcon Inc. stock pricePortfolio Return Report & Weekly Sector Rotation Insights - DonanımHaber
Is Alcon Inc. stock trading at a premium valuationPortfolio Risk Report & Free Community Consensus Stock Picks - DonanımHaber
Will Alcon Inc. stock deliver long term returnsPrice Action & Safe Entry Point Alerts - DonanımHaber
Aug Technicals: Does Alcon Inc. stock trade at a discount to peersPortfolio Gains Report & Low Risk High Win Rate Picks - DonanımHaber
How Alcon Inc. (ALC) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR) - Seeking Alpha
Defender Capital to vote against STAAR Surgical sale to Alcon By Investing.com - Investing.com Nigeria
Broadwood (NASDAQ: STAA) opposes Alcon buyout and plans STAAR board shake-up - Stock Titan
Defender Capital to vote against STAAR Surgical sale to Alcon - Investing.com India
Defender Capital reiterates intention to vote against Staar Surgical's proposed sale to Alcon Inc. - marketscreener.com
Alcon (ALC) Acquisition of STAAR Surgical Faces Strong Oppositio - GuruFocus
STAAR urges stockholders to vote for Alcon merger amid proxy battle - Investing.com Nigeria
Broadwood urges shareholders to reject Alcon’s bid for STAAR - Investing.com
Broadwood urges shareholders to reject Alcon’s bid for STAAR By Investing.com - Investing.com South Africa
Big STAAR investor fights Alcon buyout, says shares should hit $50 - Stock Titan
STAAR urges stockholders to vote for Alcon merger amid proxy battle By Investing.com - Investing.com South Africa
Alcon (ALC) Merger Proposal Faces Crucial Vote by STAAR Sharehol - GuruFocus
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value - marketscreener.com
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value | ALC Stock News - Stock Titan
Bernstein Bullish on Alcon's FY26 Earnings Growth Momentum; Outperform Maintained - marketscreener.com
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company - MSN
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon - Investing.com India
STAAR Surgical (NASDAQ: STAA) faces proxy fight over Alcon merger bid - Stock Titan
STAAR Surgical (NASDAQ: STAA) investor Yunqi Capital urges no vote on Alcon deal - Stock Titan
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
Yunqi Capital to vote against revised Alcon-STAAR merger offer By Investing.com - Investing.com South Africa
Yunqi Capital to vote against revised Alcon-STAAR merger offer - Investing.com
Yunqi Capital Opposes Alcon's Acquisition Proposal for STAAR Sur - GuruFocus
Yunqi Capital says remains opposed to STAAR’s proposed merger with Alcon - TipRanks
5.1% STAAR owner fights Alcon deal, arguing company is worth more - Stock Titan
Broadwood Partners Comments on ISS Report on of STAAR Surgical to Alcon - marketscreener.com
Alcon raises STAAR Surgical acquisition offer to $30.75 per share - Investing.com India
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):